Dr. Michal Young, M.D

NPI: 1851390801
Total Payments
$620.69
2020 Payments
$68.37
Companies
4
Transactions
11

Payment Breakdown by Category

Food & Beverage$370.36 (59.7%)
Travel$232.33 (37.4%)
Education$18.00 (2.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $370.36 8 59.7%
Travel and Lodging $232.33 2 37.4%
Education $18.00 1 2.9%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $495.35 7 $0 (2017)
SOBI, INC $89.15 2 $0 (2020)
GENZYME CORPORATION $18.38 1 $0 (2018)
Novo Nordisk Inc $17.81 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2020 $68.37 1 SOBI, INC ($68.37)
2019 $20.78 1 Sobi, Inc ($20.78)
2018 $36.19 2 GENZYME CORPORATION ($18.38)
2017 $495.35 7 AstraZeneca Pharmaceuticals LP ($495.35)

All Payment Transactions

11 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/06/2020 SOBI, INC SYNAGIS (Drug) Food and Beverage In-kind items and services $68.37 General
Category: IMMUNOLOGY
09/03/2019 Sobi, Inc Synagis (Drug) Food and Beverage In-kind items and services $20.78 General
Category: Immunology
06/01/2018 GENZYME CORPORATION DISEASE STATE (Drug) Food and Beverage In-kind items and services $18.38 General
05/24/2018 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $17.81 General
Category: Diabetes
04/15/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Travel and Lodging In-kind items and services $217.35 General
Category: Respiratory
04/15/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Food and Beverage In-kind items and services $112.68 General
Category: Respiratory
04/15/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Food and Beverage In-kind items and services $64.82 General
Category: Respiratory
04/15/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Food and Beverage In-kind items and services $43.21 General
Category: Respiratory
04/15/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Food and Beverage In-kind items and services $24.31 General
Category: Respiratory
04/15/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Travel and Lodging In-kind items and services $14.98 General
Category: Respiratory
02/21/2017 AstraZeneca Pharmaceuticals LP SYNAGIS (Biological) Education In-kind items and services $18.00 General
Category: Respiratory

About Dr. Michal Young, M.D

Dr. Michal Young, M.D is a Neonatal-Perinatal Medicine healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851390801.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michal Young, M.D has received a total of $620.69 in payments from pharmaceutical and medical device companies, with $68.37 received in 2020. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($370.36).

Practice Information

  • Specialty Neonatal-Perinatal Medicine
  • Location Washington, DC
  • Active Since 07/20/2005
  • Last Updated 07/08/2007
  • Taxonomy Code 2080N0001X
  • Entity Type Individual
  • NPI Number 1851390801

Products in Payments

  • SYNAGIS (Biological) $495.35
  • SYNAGIS (Drug) $68.37
  • Synagis (Drug) $20.78
  • DISEASE STATE (Drug) $18.38
  • Ozempic (Drug) $17.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neonatal-Perinatal Medicine Doctors in Washington